Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update
Recently Commenced Patient Enrollment in Phase 1/2 CAReS Study of ART27.13 in the UK Reported Positive Pre-Clinical Data Associated with...
Month: April 2021
INDUSTRY SOURCE CONSULTING TO APPOINT NEW MANAGEMENT IN THE COMING WEEKS
Thomasville, GA, April 13, 2021 (GLOBE NEWSWIRE) -- Industry Source Consulting, Inc. (OTC: INSO), is pleased to announce that the...
Longeveron Announces Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer’s Disease
Study meets primary safety endpoint; positive secondary efficacy assessments support potential benefit from Lomecel-B Decline in cognitive function slower in...
Vallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential Approval
- Ongoing ADAIR SEAL study on target for pivotal data readout in second half of 2021- Target NDA filing in...
Nemaura Medical Launches BEAT®diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT™ Sensors
Loughborough, England, April 13, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
Company announcement – No. 21/ 2021 Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and...
Helsinn announces poster presentation at Academy of Managed Care Pharmacy (AMCP) 2021 Virtual Meeting evaluating healthcare resource utilization in CINV
Helsinn announces poster presentation at Academy of Managed Care Pharmacy (AMCP) 2021 Virtual Meeting evaluating healthcare resource utilization in CINV...
Extendicare Announces Timing of 2021 First Quarter Results and Conference Call
MARKHAM, Ontario, April 13, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it...
GCAC Closes Largest Revenue Deal for its Efixii ‘Seed to Seed’ Platform with Malta Based Medical Cannabis Cultivator
Phase One Efixii SaaS License for 44M Grams for the 2022 HarvestVANCOUVER, British Columbia, April 13, 2021 (GLOBE NEWSWIRE) --...
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting
Poster Presentation Highlights the Unmet Patient Need and Medical Cost Burden Associated with Hepatitis B Infection Healthcare Costs Associated with...
ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market
This Pre-Series A Funding will accelerate the growth of ImpriMed’s AI-powered predictive tool that identifies which anti-cancer drugs are most...
Yumanity Therapeutics Appoints Neuroscience Drug Development Veteran, Ajay Verma, M.D., Ph.D., Executive Vice President, Head of Research & Development
BOSTON, April 13, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a biopharmaceutical company focused on the development of innovative,...
BioCorRx Announces Submission of IND Application to the FDA for BICX104, Implantable Naltrexone
ANAHEIM, CA, April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx” or the “Company”), a...
Kane Biotech Strengthens Board with Biotech Executive
WINNIPEG, Manitoba, April 13, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), is pleased...
Clubhouse Media’s Influencer-Based Model and Las Vegas Content House Profiled in Top-25 Newspaper
Las Vegas Review-Journal Publishes Extended In-Depth Profile of Company’s Newest House and Overall Model and ProgressLOS ANGELES, April 13, 2021...
Celularity Receives Orphan Drug Designation for Natural Killer Cell Therapy CYNK-001 in the Treatment of Malignant Gliomas
FLORHAM PARK, N.J., April 13, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution...
Acutus Medical Announces FDA Clearance of AcQCross™, a Full Suite of Universal Transseptal Crossing Devices
Product Family Targets Over 300,000 Annual US Electrophysiology and Structural Heart Procedures AcQCross Transseptal Crossing Device Versatility to be utilized...
Sensus Healthcare Announces the Sale/Install of its 500th Unit
Mid-Atlantic Skin Surgery Institute in Maryland acquires a second SRT systemBOCA RATON, FL, April 13, 2021 (GLOBE NEWSWIRE) -- Sensus...
Skylight Health Announces Fourth Quarter and Full Year Fiscal 2020 Earnings Conference Call
TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a...
electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance
First-quarter 2021 revenue expected to be more than $1.1 millionNet cash used for the first quarter 2021 of approximately $4.1...